ProPhase Labs PRPH
OTC PRPH
$0.01 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

ProPhase Labs (PRPH) Gains from Sales and Divestitures (2011 - 2026)

Updated

ProPhase Labs (PRPH) recorded Gains from Sales and Divestitures of $6,000 in Q1 2026, compared with -$45,000 a year earlier.

Analysis

ProPhase Labs (PRPH) Gains from Sales and Divestitures (2011 - 2026) Analysis & Trends

For FY2025, ProPhase Labs reported Gains from Sales and Divestitures of -$955,000.

  • Across earlier years, Gains from Sales and Divestitures came in at $91,000 in FY2024 and $127,000 in FY2022.
  • The Q1 2026 figure is the highest quarterly Gains from Sales and Divestitures since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 ProPhase Labs 155,925.56 -390,074.44 226,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 6,000.00
Dec 31, 2025 -87,000.00
Jun 30, 2025 -823,000.00
Mar 31, 2025 -45,000.00
Sep 30, 2024 72,000.00
Jun 30, 2024 19,000.00
Sep 30, 2017 -295,000.00
Jun 30, 2017 -584,000.00
Mar 31, 2017 43.27 Mn
Jun 30, 2015 4,000.00
Mar 31, 2015 5,000.00
Mar 31, 2011 28,000.00
API Access

ProPhase Labs Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=PRPH&period=max&api_key=YOUR_API_KEY